Edesa Biotech Inc — Cash Flow (NASDAQ:EDSA) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities 4.99 M-13.66 M-12.28 M-6.64 M4.9 M7.3 M 10.92 M Cash from investing activities 19.07 K-6 146-5 6560—— — Cash from financing activities 7.09 M14.17 M11.63 M4.83 M592.03 K17.03 M 18.31 M Free cash flow 4.95 M-13.67 M-12.28 M-6.64 M4.9 M7.3 M 10.92 M

Новости

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.76%

Рынок акций США закрылся ростом, Dow Jones прибавил 0,76%

Акции Edesa Biotech взлетели на позитивных данных 3 фазы

Edesa Biotech stock surges on positive Phase 3 trial data

Edesa Biotech reports mortality reduction in phase 3 trial

Edesa Biotech увеличивает лимит предложения ATM до $2,26 млн

Edesa Biotech increases at-the-market offering limit to $2.26 million

Edesa Biotech, Inc. (EDSA) Presents at LSX Investival Showcase Europe 2025 - Slideshow (NASDAQ:EDSA) 2025-11-17

Edesa Biotech сообщает о положительных результатах 3 фазы для препарата от ОРДС

Edesa’s ARDS drug shows 25% reduction in death risk in phase 3 trial

Edesa Biotech reports positive Phase 3 results for ARDS drug candidate

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results